• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    Humanigen, Emergent Enter Covid-19 Partnership

    Samsung Bioepis Opens New Headquarters

    Pfizer, BioNTech Enter Vax Pact with COVAX

    FDA Approves Janssen’s CABENUVA
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    Humanigen, Emergent Enter Covid-19 Partnership

    Samsung Bioepis Opens New Headquarters

    Integrated Continuous Manufacturing ICM

    CONTINUUS Awarded $69.3M DoD Grant
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Humanigen, Emergent Enter Covid-19 Partnership

    Samsung Bioepis Opens New Headquarters

    Lilly Completes $1B Acquisition of Prevail

    Top BioPharma Form Accumulus Synergy

    Coating Place Wurster Fluid Bed Process Scaling
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Alcami

    Reed-Lane

    Aphena Pharma Solutions

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Cytovance Biologics

    Aphena Pharma Solutions

    Syngene

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Catalent Launches OneXpress Solution

    Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.

    Related CONTENT
    • Global Biosciences Co. Selects ValGenesis VLMS
    • Bioclinica Partners with Ikcon Pharma
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Charles River Partners with JADE
    Contract Pharma Staff10.01.20
    Catalent has launched its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms.
     
    The OneXpress solution aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing leveraging Catalent’s phase-appropriate scale, technologies, oral dose form network and expertise to reduce risk, complexity and cost between phases. According to the company, by eliminating the need to transition projects between multiple service providers, duplication of tasks can be avoided, API consumption can be reduced, and drug products can reach patients faster.
     
    With an integrated global network and streamlined program management, the OneXpress solution combines the expertise at Catalent’s early-phase drug development centers in Nottingham, U.K., Somerset, NJ, and San Diego in the U.S. with Catalent’s oral solid commercial manufacturing facilities.
     
    “The oral drug development path is lengthy and complex, so to maximize speed and flexibility and reduce costs, innovators need to select development partners with the expertise and capabilities that are best suited for each stage in their development cycle,” commented Jeremie Trochu, Vice President, Oral and Specialty Delivery at Catalent. “Our teams have collaborated across sites to harmonize equipment, materials and protocols, to ensure accelerated and seamless scale up from first-in-human trials to commercial launch. We successfully transferred over a dozen OneXpress projects in the last year alone.”
     
    Related Searches
    • Formulation Development
    Suggested For You
    The State of Clinical Trial Technology The State of Clinical Trial Technology
    Global Biosciences Co. Selects ValGenesis VLMS  Global Biosciences Co. Selects ValGenesis VLMS
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    Sanofi Unveils EUROAPI as Name of New European API Company Sanofi Unveils EUROAPI as Name of New European API Company
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Charles River Partners with JADE Charles River Partners with JADE
    Cytiva Delivers Modular Biologics Factory to Lonza Cytiva Delivers Modular Biologics Factory to Lonza
    Baxter, Novavax Ink Sterile Manufacturing Agreement Baxter, Novavax Ink Sterile Manufacturing Agreement
     Ionis Appoints Clinical Development EVP Ionis Appoints Clinical Development EVP
    AmbioPharm Opens New Shanghai Campus AmbioPharm Opens New Shanghai Campus
    Aurigene Pharmaceutical Services ltd. Aurigene Pharmaceutical Services ltd.
    Parexel Appoints Chief Patient Officer Parexel Appoints Chief Patient Officer
    BrickBio Inks ADC Co-Development Deal BrickBio Inks ADC Co-Development Deal
    Fujifilm to Invest $40M in New Facility Fujifilm to Invest $40M in New Facility
    Ajinomoto Bio-Pharma and Revance Therapeutics Partner Ajinomoto Bio-Pharma and Revance Therapeutics Partner

    Related Breaking News

    • Breaking News | Formulation Development | Industry News
      Hovione Launches ASD-HIPROS

      Hovione Launches ASD-HIPROS

      Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.
      Contract Pharma Staff 01.04.21

    • Breaking News | Drug Development | Formulation Development | Industry News
      Vectura, Kinaset Partner to Develop Asthma Treatment

      Vectura, Kinaset Partner to Develop Asthma Treatment

      Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.
      Contract Pharma Staff 11.30.20


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.
      Contract Pharma Staff 11.30.20

    • Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
      Cambrex Completes Edinburgh Expansion

      Cambrex Completes Edinburgh Expansion

      Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.
      Contract Pharma Staff 10.12.20

    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.
      Contract Pharma Staff 09.30.20


    • APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
      Piramal to Deliver Integrated Services to Epirium

      Piramal to Deliver Integrated Services to Epirium

      Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
      Contract Pharma Staff 08.27.20

    • Breaking News | Collaborations & Alliances | Formulation Development
      TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

      TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

      Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.
      Contract Pharma Staff 08.17.20

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.
      Contract Pharma Staff 07.28.20


    • Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
      Contract Pharma Staff 07.10.20

    • Breaking News | Collaborations & Alliances | Formulation Development
      Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler

      Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler

      Enerzair Breezhaler uses Vectura’s formulation IP, and is a first-in-class fixed-dose combination maintenance treatment for uncontrolled asthma.
      Contract Pharma Staff 07.07.20

    • Formulation Development | Industry News
      SeraNovo, Carna Biosciences Enter Second License Agreement

      SeraNovo, Carna Biosciences Enter Second License Agreement

      To develop an oral formulation of a new active ingredient with enhanced bioavailability.
      Contract Pharma Staff 05.26.20


    • Formulation Development | Industry News | Trials & Filings
      Triphase, Catalent Announce Interim TRPH-222 Results in NHL

      Triphase, Catalent Announce Interim TRPH-222 Results in NHL

      TRPH-222 leverages Catalent’s SMARTag platform to provide optimized site-specific protein-modification and linker technologies.
      Contract Pharma Staff 05.19.20

    • Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact

      Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact

      Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19
      Contract Pharma Staff 05.13.20

    • Breaking News | Formulation Development | Industry News
      Adare Pharma Acquires Orbis Biosciences

      Adare Pharma Acquires Orbis Biosciences

      Expands Adare’s technology platforms and product development capabilities.
      Contract Pharma Staff 05.05.20

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    • CONTINUUS Awarded $69.3M DoD Grant
    Breaking News
    • Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    • Humanigen, Emergent Enter Covid-19 Partnership
    • Samsung Bioepis Opens New Headquarters
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    • FDA Approves Janssen’s CABENUVA
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Oleic Acid Possibly Implicated in MS Pathology
    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    BCF CEO to Chair Royal Society of Chemistry Surface Coatings Interest Group
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alleviant's Transcatheter Tech Obtains Breakthrough Status
    Signia Appoints New President
    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Humanigen, Emergent Enter Covid-19 Partnership
    Samsung Bioepis Opens New Headquarters
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fitglow Beauty Wins Big at Annual Dirty Thinker’s Choice Awards
    e.l.f. Cosmetics Unveils Mint Melt Collection
    Estée Lauder Companies Updates Supply Chain Leadership
    Happi

    Latest Breaking News From Happi

    Some Good News at Inter Parfums
    Professional Beauty Association Names New Executive Director
    Curcumin's Role in Oral Care
    Ink World

    Latest Breaking News From Ink World

    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    VPF launches deep-freeze adhesive
    ProMach strengthens flexible packaging business
    Gallus planning virtual event for March
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    Imec Technology Taking Off to Space
    North American Semiconductor Equipment Industry Posts December 2020 Billings

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login